Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trial
- Submitting institution
-
Anglia Ruskin University Higher Education Corporation
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 829
- Type
- D - Journal article
- DOI
-
10.1186/s12916-020-01542-9
- Title of journal
- BMC Medicine
- Article number
- 91
- First page
- 91
- Volume
- 18
- Issue
- 1
- ISSN
- 1741-7015
- Open access status
- Compliant
- Month of publication
- April
- Year of publication
- 2020
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
32
- Research group(s)
-
-
- Citation count
- 4
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- Michael Almond as a co-author of “Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo controlled trial” has made a substantial contribution to the carrying out the study; analysis and interpretation of study data; helped draft the output and critiqued the output for important intellectual content.
- Non-English
- No
- English abstract
- -